Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients.

导出 OA

翻译打印收藏纠错

作者： Sameer,Farouk Sait ^[1] ; Cheryl,Fischer ^[1] ; Zoltan,Antal ^[2] ; Krisoula,Spatz ^[3] ; Daniel E,Prince ^[4] ; Katarzyna,Ibanez ^[5] ; Gerald G,Behr ^[6] ; Ira J,Dunkel ^[1] ; Matthias A,Karajannis ^[1]

作者单位： Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[1] Department of Endocrinology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[2] Department of Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[3] Department of Orthopedics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[4] Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[5] Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[6]

关键词 fibroblast growth factor receptor inhibitor skeletal toxicity slipped capital femoral epiphyses

DOI 10.1002/pbc.30410

PMID 37158537

发布时间 2024-11-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pediatric blood & cancer

e30410页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients.

Pediatric blood & cancer

相似文献

Pediatric blood & cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients.

Pediatric blood & cancer

相似文献

Pediatric blood & cancer

相关期刊

检索历史清除